Academy of Military Medical Sciences Pharmaceutical Plant

The Academy of Military Medical Sciences Pharmaceutical Plant is the primary manufacturing and industrialization arm of the Academy of Military Medical Sciences (AMMS), China's leading military medical research institution. The plant specializes in the production of essential medicines developed by AMMS research institutes, particularly focusing on anti-infectives, biodefense countermeasures, and emergency medical supplies. It is globally recognized for its role in producing the anti-malarial drug lumefantrine (benflumetol) and for its rapid response capabilities during public health crises, including the development of Ebola treatments and COVID-19 vaccines. The facility operates under strict military-industrial standards and serves as a critical pillar of China's national health security and military readiness.